Consistent with our findings for dysregulated lncRNAs in SCLC, previous studies found that lncRNAs DLX6-AS1 and NEAT1 were significantly dysregulated in non-SCLC, gastric cancer and pancreatic cancer (59–62). Here, DLX6 is linked to familial pancreatic carcinoma.